BELITE BIO (BLTE) CFO Chuang Hao‑Yuan Sells 367 Shares

What Happened
Chuang Hao‑Yuan, Chief Financial Officer of Belite Bio, sold a total of 367 American depositary shares (ADSs) in two open‑market transactions on August 12, 2026, for aggregate proceeds of $66,187. The sales were: 144 ADSs at $180.00 each ($25,920) and 223 ADSs at $180.57 each ($40,267). These were dispositions (sales), not purchases.

Key Details

• Transaction dates and prices: 8/12/2026 — 144 ADSs @ $180.00; 223 ADSs @ $180.57.
• Total shares sold: 367 ADSs; total proceeds: $66,187.
• Footnotes: F1 — each ADS represents one ordinary share of the issuer; F2 — sales were made pursuant to a Rule 10b5‑1 trading plan adopted by the insider on 12/22/2025.
• Filing: Form 4 filed 8/14/2026, two days after the transactions (appears timely under Form 4 rules).
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context
Sales made under a Rule 10b5‑1 plan are prearranged transactions that can be executed automatically and are commonly used by insiders to avoid the appearance of opportunistic trading; they do not, by themselves, indicate the insider’s current view of the company’s prospects. As these were sales (not purchases), they are typically seen as routine disclosures rather than a bullish signal.